Adams Asset Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Adams Asset Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.21M	Buy	125,138 +1,844	+1%	+$106K	0.82%	34
2026 Q1	$7.48M	Hold	123,294	–	–	0.84%	33
2025 Q4	$6.65M	Buy	123,294 +2,236	+2%	+$108K	0.88%	32
2025 Q3	$5.46M	Sell	121,058 -3,414	-3%	-$159K	0.7%	36
2025 Q2	$5.76M	Sell	124,472 -23,295	-16%	-$1.14M	0.81%	36
2025 Q1	$9.01M	Sell	147,767 -15,440	-9%	-$900K	1.24%	27
2024 Q4	$9.23M	Buy	163,207 +171	+0.1%	+$9.55K	1.19%	26
2024 Q3	$8.44M	Buy	163,036 +1,807	+1%	+$84.8K	1.12%	29
2024 Q2	$6.7M	Sell	161,229 -16,944	-10%	-$758K	0.87%	35
2024 Q1	$9.66M	Buy	178,173 +1,920	+1%	+$97.8K	1.25%	25
2023 Q4	$9.04M	Buy	176,253 +170,753	+3,105%	+$8.96M	1.22%	26
2023 Q3	$319K	Hold	5,500	–	–	0.04%	69
2023 Q2	$352K	Hold	5,500	–	–	0.05%	72
2023 Q1	$381K	Hold	5,500	–	–	0.05%	74
2022 Q4	$396K	Sell	5,500 -10	-0.2%	-$754	0.05%	74
2022 Q3	$391K	Hold	5,510	–	–	0.06%	62
2022 Q2	$424K	Hold	5,510	–	–	0.06%	67
2022 Q1	$402K	Hold	5,510	–	–	0.06%	64
2021 Q4	$343K	Hold	5,510	–	–	0.06%	69
2021 Q3	$326K	Hold	5,510	–	–	0.07%	69
2021 Q2	$368K	Hold	5,510	–	–	0.07%	72
2021 Q1	$347K	Hold	5,510	–	–	0.07%	70
2020 Q4	$341K	Hold	5,510	–	–	0.09%	67
2020 Q3	$332K	Hold	5,510	–	–	0.11%	65
2020 Q2	$323K	Buy	+5,510	New	+$330K	0.1%	67

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Adams Asset Advisors's BMY Position: Q2 2026 in Review

Adams Asset Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.5% in Q2 2026, buying an estimated $106K and bringing the position to 125,138 shares worth $7.21M. The position accounts for 0.82% of the portfolio, ranked #34.

Adams Asset Advisors first reported a position in BMY in Q2 2020 and has held it in 25 quarters since. The position peaked at $9.66M in Q1 2024. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Adams Asset Advisors held 125,138 shares of Bristol-Myers Squibb worth $7.21M as of Q2 2026.
Adams Asset Advisors bought 1,844 Bristol-Myers Squibb shares in Q2 2026, an estimated $106K.
Bristol-Myers Squibb made up 0.82% of Adams Asset Advisors's portfolio in Q2 2026, its #34 holding.
Adams Asset Advisors first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 25 quarters since.
Adams Asset Advisors's Bristol-Myers Squibb position peaked at $9.66M in Q1 2024.
814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Adams Asset Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.